Industry Research Reports
Home > Reports > Chemical & Material > Erythromycin Thiocyanate API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Erythromycin Thiocyanate API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 95 Pages
Report ld: 4518266
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Erythromycin Thiocyanate API Market Size(US$)
CAGR 2025-2031
5.5%
Market Size,2031
USD 2,387
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,731 million
Market Forecast in 2031(Value)
US$ 2,387 million
CAGR
5.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
North American market for Erythromycin Thiocyanate API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Erythromycin Thiocyanate API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Erythromycin Thiocyanate API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Erythromycin Thiocyanate API include Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, HEC Group, AbbVie, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Erythromycin Thiocyanate API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Erythromycin Thiocyanate API by region & country, by Type, and by Application.
The Erythromycin Thiocyanate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythromycin Thiocyanate API.
MARKET SEGMENTATION
By Company
- Yili Chuannig Biotechnology
- Yichang East Sunshine
- Alebi Pharma
- META Pharmaceuticals
- Anuh Pharma
- HEC Group
- AbbVie
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Industrial Grade
- Feed Grade
- Pharmaceutical Grade
Segment by Application
- Erythromycin Synthesis
- Feed Additive
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Erythromycin Thiocyanate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Erythromycin Thiocyanate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Erythromycin Thiocyanate API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Erythromycin Thiocyanate API Product Introduction
1.2 Global Erythromycin Thiocyanate API Market Size Forecast
1.2.1 Global Erythromycin Thiocyanate API Sales Value (2020-2031)
1.2.2 Global Erythromycin Thiocyanate API Sales Volume (2020-2031)
1.2.3 Global Erythromycin Thiocyanate API Sales Price (2020-2031)
1.3 Erythromycin Thiocyanate API Market Trends & Drivers
1.3.1 Erythromycin Thiocyanate API Industry Trends
1.3.2 Erythromycin Thiocyanate API Market Drivers & Opportunity
1.3.3 Erythromycin Thiocyanate API Market Challenges
1.3.4 Erythromycin Thiocyanate API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Erythromycin Thiocyanate API Players Revenue Ranking (2024)
2.2 Global Erythromycin Thiocyanate API Revenue by Company (2020-2025)
2.3 Global Erythromycin Thiocyanate API Players Sales Volume Ranking (2024)
2.4 Global Erythromycin Thiocyanate API Sales Volume by Company Players (2020-2025)
2.5 Global Erythromycin Thiocyanate API Average Price by Company (2020-2025)
2.6 Key Manufacturers Erythromycin Thiocyanate API Manufacturing Base and Headquarters
2.7 Key Manufacturers Erythromycin Thiocyanate API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Erythromycin Thiocyanate API
2.9 Erythromycin Thiocyanate API Market Competitive Analysis
2.9.1 Erythromycin Thiocyanate API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Erythromycin Thiocyanate API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythromycin Thiocyanate API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Industrial Grade
3.1.2 Feed Grade
3.1.3 Pharmaceutical Grade
3.2 Global Erythromycin Thiocyanate API Sales Value by Type
3.2.1 Global Erythromycin Thiocyanate API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Erythromycin Thiocyanate API Sales Value, by Type (2020-2031)
3.2.3 Global Erythromycin Thiocyanate API Sales Value, by Type (%) (2020-2031)
3.3 Global Erythromycin Thiocyanate API Sales Volume by Type
3.3.1 Global Erythromycin Thiocyanate API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Erythromycin Thiocyanate API Sales Volume, by Type (2020-2031)
3.3.3 Global Erythromycin Thiocyanate API Sales Volume, by Type (%) (2020-2031)
3.4 Global Erythromycin Thiocyanate API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Erythromycin Synthesis
4.1.2 Feed Additive
4.2 Global Erythromycin Thiocyanate API Sales Value by Application
4.2.1 Global Erythromycin Thiocyanate API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Erythromycin Thiocyanate API Sales Value, by Application (2020-2031)
4.2.3 Global Erythromycin Thiocyanate API Sales Value, by Application (%) (2020-2031)
4.3 Global Erythromycin Thiocyanate API Sales Volume by Application
4.3.1 Global Erythromycin Thiocyanate API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Erythromycin Thiocyanate API Sales Volume, by Application (2020-2031)
4.3.3 Global Erythromycin Thiocyanate API Sales Volume, by Application (%) (2020-2031)
4.4 Global Erythromycin Thiocyanate API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Erythromycin Thiocyanate API Sales Value by Region
5.1.1 Global Erythromycin Thiocyanate API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Erythromycin Thiocyanate API Sales Value by Region (2020-2025)
5.1.3 Global Erythromycin Thiocyanate API Sales Value by Region (2026-2031)
5.1.4 Global Erythromycin Thiocyanate API Sales Value by Region (%), (2020-2031)
5.2 Global Erythromycin Thiocyanate API Sales Volume by Region
5.2.1 Global Erythromycin Thiocyanate API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Erythromycin Thiocyanate API Sales Volume by Region (2020-2025)
5.2.3 Global Erythromycin Thiocyanate API Sales Volume by Region (2026-2031)
5.2.4 Global Erythromycin Thiocyanate API Sales Volume by Region (%), (2020-2031)
5.3 Global Erythromycin Thiocyanate API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Erythromycin Thiocyanate API Sales Value, 2020-2031
5.4.2 North America Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Erythromycin Thiocyanate API Sales Value, 2020-2031
5.5.2 Europe Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Erythromycin Thiocyanate API Sales Value, 2020-2031
5.6.2 Asia Pacific Erythromycin Thiocyanate API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Erythromycin Thiocyanate API Sales Value, 2020-2031
5.7.2 South America Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Erythromycin Thiocyanate API Sales Value, 2020-2031
5.8.2 Middle East & Africa Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Erythromycin Thiocyanate API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Erythromycin Thiocyanate API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Erythromycin Thiocyanate API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Erythromycin Thiocyanate API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Erythromycin Thiocyanate API Sales Value, 2020-2031
6.3.2 United States Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Erythromycin Thiocyanate API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Erythromycin Thiocyanate API Sales Value, 2020-2031
6.4.2 Europe Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Erythromycin Thiocyanate API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Erythromycin Thiocyanate API Sales Value, 2020-2031
6.5.2 China Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Erythromycin Thiocyanate API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Erythromycin Thiocyanate API Sales Value, 2020-2031
6.6.2 Japan Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Erythromycin Thiocyanate API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Erythromycin Thiocyanate API Sales Value, 2020-2031
6.7.2 South Korea Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Erythromycin Thiocyanate API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Erythromycin Thiocyanate API Sales Value, 2020-2031
6.8.2 Southeast Asia Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Erythromycin Thiocyanate API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Erythromycin Thiocyanate API Sales Value, 2020-2031
6.9.2 India Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Erythromycin Thiocyanate API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Yili Chuannig Biotechnology
7.1.1 Yili Chuannig Biotechnology Company Information
7.1.2 Yili Chuannig Biotechnology Introduction and Business Overview
7.1.3 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Product Offerings
7.1.5 Yili Chuannig Biotechnology Recent Development
7.2 Yichang East Sunshine
7.2.1 Yichang East Sunshine Company Information
7.2.2 Yichang East Sunshine Introduction and Business Overview
7.2.3 Yichang East Sunshine Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Yichang East Sunshine Erythromycin Thiocyanate API Product Offerings
7.2.5 Yichang East Sunshine Recent Development
7.3 Alebi Pharma
7.3.1 Alebi Pharma Company Information
7.3.2 Alebi Pharma Introduction and Business Overview
7.3.3 Alebi Pharma Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Alebi Pharma Erythromycin Thiocyanate API Product Offerings
7.3.5 Alebi Pharma Recent Development
7.4 META Pharmaceuticals
7.4.1 META Pharmaceuticals Company Information
7.4.2 META Pharmaceuticals Introduction and Business Overview
7.4.3 META Pharmaceuticals Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 META Pharmaceuticals Erythromycin Thiocyanate API Product Offerings
7.4.5 META Pharmaceuticals Recent Development
7.5 Anuh Pharma
7.5.1 Anuh Pharma Company Information
7.5.2 Anuh Pharma Introduction and Business Overview
7.5.3 Anuh Pharma Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Anuh Pharma Erythromycin Thiocyanate API Product Offerings
7.5.5 Anuh Pharma Recent Development
7.6 HEC Group
7.6.1 HEC Group Company Information
7.6.2 HEC Group Introduction and Business Overview
7.6.3 HEC Group Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 HEC Group Erythromycin Thiocyanate API Product Offerings
7.6.5 HEC Group Recent Development
7.7 AbbVie
7.7.1 AbbVie Company Information
7.7.2 AbbVie Introduction and Business Overview
7.7.3 AbbVie Erythromycin Thiocyanate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 AbbVie Erythromycin Thiocyanate API Product Offerings
7.7.5 AbbVie Recent Development
8 Industry Chain Analysis
8.1 Erythromycin Thiocyanate API Industrial Chain
8.2 Erythromycin Thiocyanate API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Erythromycin Thiocyanate API Sales Model
8.5.2 Sales Channel
8.5.3 Erythromycin Thiocyanate API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Erythromycin Thiocyanate API Market Trends
Table 2. Erythromycin Thiocyanate API Market Drivers & Opportunity
Table 3. Erythromycin Thiocyanate API Market Challenges
Table 4. Erythromycin Thiocyanate API Market Restraints
Table 5. Global Erythromycin Thiocyanate API Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Erythromycin Thiocyanate API Revenue Market Share by Company (2020-2025)
Table 7. Global Erythromycin Thiocyanate API Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Erythromycin Thiocyanate API Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Erythromycin Thiocyanate API Price by Company (2020-2025) & (US$/Ton)
Table 10. Key Manufacturers Erythromycin Thiocyanate API Manufacturing Base and Headquarters
Table 11. Key Manufacturers Erythromycin Thiocyanate API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Erythromycin Thiocyanate API
Table 13. Global Erythromycin Thiocyanate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythromycin Thiocyanate API as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Erythromycin Thiocyanate API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Erythromycin Thiocyanate API Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Erythromycin Thiocyanate API Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Erythromycin Thiocyanate API Sales Market Share in Value by Type (2020-2025)
Table 20. Global Erythromycin Thiocyanate API Sales Market Share in Value by Type (2026-2031)
Table 21. Global Erythromycin Thiocyanate API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Erythromycin Thiocyanate API Sales Volume by Type (2020-2025) & (Tons)
Table 23. Global Erythromycin Thiocyanate API Sales Volume by Type (2026-2031) & (Tons)
Table 24. Global Erythromycin Thiocyanate API Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Erythromycin Thiocyanate API Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Erythromycin Thiocyanate API Price by Type (2020-2025) & (US$/Ton)
Table 27. Global Erythromycin Thiocyanate API Price by Type (2026-2031) & (US$/Ton)
Table 28. Global Erythromycin Thiocyanate API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Erythromycin Thiocyanate API Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Erythromycin Thiocyanate API Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Erythromycin Thiocyanate API Sales Market Share in Value by Application (2020-2025)
Table 32. Global Erythromycin Thiocyanate API Sales Market Share in Value by Application (2026-2031)
Table 33. Global Erythromycin Thiocyanate API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Erythromycin Thiocyanate API Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Erythromycin Thiocyanate API Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Erythromycin Thiocyanate API Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Erythromycin Thiocyanate API Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Erythromycin Thiocyanate API Price by Application (2020-2025) & (US$/Ton)
Table 39. Global Erythromycin Thiocyanate API Price by Application (2026-2031) & (US$/Ton)
Table 40. Global Erythromycin Thiocyanate API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Erythromycin Thiocyanate API Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Erythromycin Thiocyanate API Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Erythromycin Thiocyanate API Sales Value by Region (2020-2025) & (%)
Table 44. Global Erythromycin Thiocyanate API Sales Value by Region (2026-2031) & (%)
Table 45. Global Erythromycin Thiocyanate API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Erythromycin Thiocyanate API Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Erythromycin Thiocyanate API Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Erythromycin Thiocyanate API Sales Volume by Region (2020-2025) & (%)
Table 49. Global Erythromycin Thiocyanate API Sales Volume by Region (2026-2031) & (%)
Table 50. Global Erythromycin Thiocyanate API Average Price by Region (2020-2025) & (US$/Ton)
Table 51. Global Erythromycin Thiocyanate API Average Price by Region (2026-2031) & (US$/Ton)
Table 52. Key Countries/Regions Erythromycin Thiocyanate API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Erythromycin Thiocyanate API Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Erythromycin Thiocyanate API Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Erythromycin Thiocyanate API Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Erythromycin Thiocyanate API Sales Volume, (2026-2031) & (Tons)
Table 57. Yili Chuannig Biotechnology Company Information
Table 58. Yili Chuannig Biotechnology Introduction and Business Overview
Table 59. Yili Chuannig Biotechnology Erythromycin Thiocyanate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 60. Yili Chuannig Biotechnology Erythromycin Thiocyanate API Product Offerings
Table 61. Yili Chuannig Biotechnology Recent Development
Table 62. Yichang East Sunshine Company Information
Table 63. Yichang East Sunshine Introduction and Business Overview
Table 64. Yichang East Sunshine Erythromycin Thiocyanate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. Yichang East Sunshine Erythromycin Thiocyanate API Product Offerings
Table 66. Yichang East Sunshine Recent Development
Table 67. Alebi Pharma Company Information
Table 68. Alebi Pharma Introduction and Business Overview
Table 69. Alebi Pharma Erythromycin Thiocyanate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Alebi Pharma Erythromycin Thiocyanate API Product Offerings
Table 71. Alebi Pharma Recent Development
Table 72. META Pharmaceuticals Company Information
Table 73. META Pharmaceuticals Introduction and Business Overview
Table 74. META Pharmaceuticals Erythromycin Thiocyanate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. META Pharmaceuticals Erythromycin Thiocyanate API Product Offerings
Table 76. META Pharmaceuticals Recent Development
Table 77. Anuh Pharma Company Information
Table 78. Anuh Pharma Introduction and Business Overview
Table 79. Anuh Pharma Erythromycin Thiocyanate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Anuh Pharma Erythromycin Thiocyanate API Product Offerings
Table 81. Anuh Pharma Recent Development
Table 82. HEC Group Company Information
Table 83. HEC Group Introduction and Business Overview
Table 84. HEC Group Erythromycin Thiocyanate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. HEC Group Erythromycin Thiocyanate API Product Offerings
Table 86. HEC Group Recent Development
Table 87. AbbVie Company Information
Table 88. AbbVie Introduction and Business Overview
Table 89. AbbVie Erythromycin Thiocyanate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. AbbVie Erythromycin Thiocyanate API Product Offerings
Table 91. AbbVie Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Erythromycin Thiocyanate API Downstream Customers
Table 95. Erythromycin Thiocyanate API Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Erythromycin Thiocyanate API Product Picture
Figure 2. Global Erythromycin Thiocyanate API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Erythromycin Thiocyanate API Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Erythromycin Thiocyanate API Sales Volume (2020-2031) & (Tons)
Figure 5. Global Erythromycin Thiocyanate API Sales Price (2020-2031) & (US$/Ton)
Figure 6. Erythromycin Thiocyanate API Report Years Considered
Figure 7. Global Erythromycin Thiocyanate API Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Erythromycin Thiocyanate API Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Erythromycin Thiocyanate API Revenue in 2024
Figure 10. Erythromycin Thiocyanate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Industrial Grade Picture
Figure 12. Feed Grade Picture
Figure 13. Pharmaceutical Grade Picture
Figure 14. Global Erythromycin Thiocyanate API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Erythromycin Thiocyanate API Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Erythromycin Thiocyanate API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
Figure 17. Global Erythromycin Thiocyanate API Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Erythromycin Thiocyanate API Price by Type (2020-2031) & (US$/Ton)
Figure 19. Product Picture of Erythromycin Synthesis
Figure 20. Product Picture of Feed Additive
Figure 21. Global Erythromycin Thiocyanate API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Erythromycin Thiocyanate API Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Erythromycin Thiocyanate API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 24. Global Erythromycin Thiocyanate API Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Erythromycin Thiocyanate API Price by Application (2020-2031) & (US$/Ton)
Figure 26. North America Erythromycin Thiocyanate API Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Erythromycin Thiocyanate API Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Erythromycin Thiocyanate API Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Erythromycin Thiocyanate API Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Erythromycin Thiocyanate API Sales Volume (%), (2020-2031)
Figure 38. United States Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Erythromycin Thiocyanate API Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Erythromycin Thiocyanate API Sales Value by Application (%), 2024 VS 2031
Figure 44. China Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
Figure 46. China Erythromycin Thiocyanate API Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Erythromycin Thiocyanate API Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Erythromycin Thiocyanate API Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Erythromycin Thiocyanate API Sales Value by Application (%), 2024 VS 2031
Figure 56. India Erythromycin Thiocyanate API Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Erythromycin Thiocyanate API Sales Value by Type (%), 2024 VS 2031
Figure 58. India Erythromycin Thiocyanate API Sales Value by Application (%), 2024 VS 2031
Figure 59. Erythromycin Thiocyanate API Industrial Chain
Figure 60. Erythromycin Thiocyanate API Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Erythromycin Thiocyanate API in 2025?
The global market size of Erythromycin Thiocyanate API in 2025 was 1731 Million USD.
Which companies rank high in the global Erythromycin Thiocyanate API market?
What is the annual compound growth rate of the global Erythromycin Thiocyanate API market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Erythromycin Thiocyanate API in 2031?
Related Reports
Global Erythromycin Thiocyanate API Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 143
USD 4900.00
(Single User License)
Global Erythromycin Thiocyanate API Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
Erythromycin Thiocyanate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 95
USD 3950.00
(Single User License)
Global Erythromycin Thiocyanate API Market Research Report 2026
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 129
USD 2900.00
(Single User License)
Global Erythromycin Thiocyanate API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
Global Erythromycin Thiocyanate API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 78
USD 4250.00
(Single User License)
Global Erythromycin Thiocyanate API Market Research Report 2025
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-03-10
Pages: 89
USD 2900.00
(Single User License)
Global Erythromycin Thiocyanate API Market Research Report 2024
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 91
USD 2900.00
(Single User License)
Global and United States Erythromycin Thiocyanate API Market Report & Forecast 2024-2030
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 108
USD 4350.00
(Single User License)
Global Erythromycin Thiocyanate API Market Insights, Forecast to 2030
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 137
USD 4900.00
(Single User License)
Global Erythromycin Thiocyanate API Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 143
USD 4900.00 (Single User License)Global Erythromycin Thiocyanate API Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
USD 4250.00 (Single User License)Erythromycin Thiocyanate API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 95
USD 3950.00 (Single User License)Global Erythromycin Thiocyanate API Market Research Report 2026
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 129
USD 2900.00 (Single User License)Global Erythromycin Thiocyanate API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
USD 4900.00 (Single User License)Global Erythromycin Thiocyanate API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 78
USD 4250.00 (Single User License)Global Erythromycin Thiocyanate API Market Research Report 2025
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 89
USD 2900.00 (Single User License)Global Erythromycin Thiocyanate API Market Research Report 2024
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 91
USD 2900.00 (Single User License)Global and United States Erythromycin Thiocyanate API Market Report & Forecast 2024-2030
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 108
USD 4350.00 (Single User License)Global Erythromycin Thiocyanate API Market Insights, Forecast to 2030
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 137
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now